ComplyRx
Built by ComplyRx

Compare clinical trial pipelines, export for presentations

dapagliflozin (16) vs empagliflozin (16)17 active2008–2032
dapagliflozinempagliflozin
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingEnrolling by invitationNot yet recruitingCompletedSuspendedUnknown status
'08
'10
'12
'14
'16
'18
'20
'22
'24
'26
'28
'30
'32
dapagliflozin
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesP3
A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 DiabetesP3
Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsP4
READP4
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus PatientsP4
STARTP3
SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney DiseaseP2
DAPA-PCI-AKIP4
STEPSP4
SYNCARDIA-HFP2
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusP3
KETO-TRACKP2
Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian SyndromeP3
Elevate-CKDP3
aDAPt-ANOCAP2
RELIEF-ASP2
empagliflozin
12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic PatientsP2
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).P3
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 DiabetesP3
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)P3
EMPA-HEARTP4
The Effects of Empagliflozin on Arterial Wall CharacteristicsP4
SUGAR-DM-HFP4
Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study ProtocolP4
A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart FailureP3
The CANA -AHFP3
EMPAP3
SGLT2i VS ACEiP2
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese PatientP4
STEPSP4
TIME-SGLT2P3
EMPA-CONP3

Upcoming readouts

9 ahead · 2 drugs

Select a trial to load its full ClinicalTrials.gov record.

Trial Pipeline · How it works

Search, compare, export.

Three steps from drug name to a presentation-ready pipeline view, with live trial data, side by side.

  1. 01 · SEARCH

    Search drugs

    Type a drug name and see the phase 2-4 trials from ClinicalTrials.gov.

  2. 02 · COMPARE

    Compare timelines

    See start dates, primary completions, and status on one timeline, up to five drugs at once.

  3. 03 · EXPORT

    Export for your deck

    Download a branded PNG or PDF. Share the URL. Every comparison state is linkable.

FAQ

Where does the data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov). Results are cached for up to 6 hours so repeat loads stay fast.
Is this free?
Yes. Compare up to five drugs and export PNG or PDF at no cost. Export requires a one-time email to join the ComplyRx waitlist.
What is ComplyRx?
ComplyRx is an all-in-one marketing/competitive intelligence platform for organisations and individuals that work in healthcare, life sciences, and the pharmaceutical industry.

Keep following
what matters.

Choose the drugs, companies or disease areas you follow. Bring trial changes and upcoming readouts into one watch.

Build your watch

Choose what to track in the watch builder.